Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti… - The Lancet Infectious …, 2021 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …
COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment
A Arastehfar, A Carvalho, FL van de Veerdonk… - Journal of Fungi, 2020 - mdpi.com
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory
distress syndrome (ARDS) has emerged as an important disease that predisposes patients …
distress syndrome (ARDS) has emerged as an important disease that predisposes patients …
Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium
The high clinical mortality and economic burden posed by invasive fungal infections (IFIs),
along with significant agricultural crop loss caused by various fungal species, has resulted in …
along with significant agricultural crop loss caused by various fungal species, has resulted in …
COVID-19-associated opportunistic infections: a snapshot on the current reports
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …
complicated challenge, especially among patients with severe disease. In recent studies …
Breakthrough invasive fungal infections: Who is at risk?
The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has
changed over the last few decades, partially due to the increased use of antifungal agents to …
changed over the last few decades, partially due to the increased use of antifungal agents to …
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …
aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …
Mucormycosis treatment: Recommendations, latest advances, and perspectives
K Brunet, B Rammaert - Journal de mycologie medicale, 2020 - Elsevier
Mucormycosis are life-threatening fungal infections especially affecting
immunocompromised or diabetic patients. Despite treatment, mortality remains high (from 32 …
immunocompromised or diabetic patients. Despite treatment, mortality remains high (from 32 …
Aspergillus fumigatus and aspergillosis: From basics to clinics
The airborne fungus Aspergillus fumigatus poses a serious health threat to humans by
causing numerous invasive infections and a notable mortality in humans, especially in …
causing numerous invasive infections and a notable mortality in humans, especially in …
Treatment of invasive aspergillosis: how it's going, where it's heading
Despite improvements in treatment and diagnostics over the last two decades, invasive
aspergillosis (IA) remains a devastating fungal disease. The number of …
aspergillosis (IA) remains a devastating fungal disease. The number of …
Antifungal drugs TDM: trends and update
B Kably, M Launay, A Derobertmasure… - Therapeutic Drug …, 2022 - journals.lww.com
Purpose: The increasing burden of invasive fungal infections results in growing challenges
to antifungal (AF) therapeutic drug monitoring (TDM). This review aims to provide an …
to antifungal (AF) therapeutic drug monitoring (TDM). This review aims to provide an …